论文部分内容阅读
９６４～１９８５年收治复发性宫颈癌１３７例，其中根治术后复发７３例，首选经典放疗法６４例。本组患者再治前经病理诊断者７３例，治疗期获病理确认者４７例，影像诊断８例，另９例是依据肿块、疼痛加重、或加下肢肿大等诊为复发。复发癌灶位中央（子宫或阴道）的６６例，在盆壁出现者２８例，中央及盆壁均有癌者２４例，肺、锁上区或骨骼癌转移１９例。再治疗方法根据个别病例经认真研究后制定。以放疗或加中药治疗者９２例；插管化疗（大多经动脉插管化疗）２６例；手术处理者１３例均为放疗后复发者；化疗加放疗６例。１３７例再治疗后，随诊５～２８年，随诊率为９６．４％。生存５年或以上者５６例均有病理诊断。全组的５年生存率为４０．９％，１３例复发癌经手术治疗５年生存达５３．８％，无癌生存最长１例有２８年余。
From September64 to 1985, 137 cases of recurrent cervical cancer were treated, of which 73 cases were recurred after radical operation, and 64 cases were the first choice of classical radiotherapy. The group of patients before re-treatment pathological diagnosis of 73 cases, the treatment of pathological confirmed by 47 cases, 8 cases of imaging diagnosis, the other 9 cases are based on mass, pain, or lower extremity swollen for the diagnosis of recurrence. There were 66 cases of recurrent foci (uterus or vagina) in the pelvis, 28 cases in the pelvis, 24 cases of cancer in the center and pelvic wall, and 19 cases of metastasis in lung, locked area or skeletal cancer. Re-treatment according to individual cases after careful study to develop. There were 92 cases treated with radiotherapy or traditional Chinese medicine; 26 cases received intubation chemotherapy (mostly arterial intubation chemotherapy); 13 cases treated by surgery were recurrence after radiotherapy; 6 cases were treated with chemotherapy and radiotherapy. 137 cases of re-treatment, followed up for 5 to 28 years, the follow-up rate was 96.4%. 56 cases survived for 5 years or more had pathological diagnosis. The 5-year overall survival rate was 40.9%, 13 cases of recurrent cancer by 5-year survival of 53.8%, cancer-free survival of 1 case more than 28 years.